Page last updated: 2024-10-24

chloroquine and Dysplastic Nevus Syndrome, Hereditary

chloroquine has been researched along with Dysplastic Nevus Syndrome, Hereditary in 1 studies

Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.

Research Excerpts

ExcerptRelevanceReference
"Melanoma is one of the most common skin infections, has triggered significant morbidity and mortality across the globe."5.72In silico-prediction of chloroquine as a multi-targeted drug against CDKN2A signaling network associated with cutaneous malignant melanoma. ( Aqeel, M; Awan, L; Bashir, Z; Jan, Z; Kalsoom, S; Muhammad Ali, G; Munir, A; Nadeem, T; Sadia, H; Saeed, A; Ud Din, S, 2022)
"Melanoma is one of the most common skin infections, has triggered significant morbidity and mortality across the globe."1.72In silico-prediction of chloroquine as a multi-targeted drug against CDKN2A signaling network associated with cutaneous malignant melanoma. ( Aqeel, M; Awan, L; Bashir, Z; Jan, Z; Kalsoom, S; Muhammad Ali, G; Munir, A; Nadeem, T; Sadia, H; Saeed, A; Ud Din, S, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Jan, Z1
Aqeel, M1
Munir, A1
Saeed, A1
Sadia, H1
Kalsoom, S1
Nadeem, T1
Bashir, Z1
Awan, L1
Ud Din, S1
Muhammad Ali, G1

Other Studies

1 other study available for chloroquine and Dysplastic Nevus Syndrome, Hereditary

ArticleYear
In silico-prediction of chloroquine as a multi-targeted drug against CDKN2A signaling network associated with cutaneous malignant melanoma.
    Pakistan journal of pharmaceutical sciences, 2022, Volume: 35, Issue:3

    Topics: Chloroquine; Cyclin-Dependent Kinase Inhibitor p16; Humans; Melanoma; Melanoma, Cutaneous Malignant;

2022